U.S. Healthcare Services Stock News

Rapport Therapeutics (RAPP) has drawn fresh attention after signing a partnership with Tenacia Biotechnology that gives Tenacia exclusive rights to develop and commercialize RAP-219 across Greater China. See our latest analysis for Rapport Therapeutics. The Tenacia deal lands at a time when momentum in Rapport Therapeutics’ shares has been positive, with a 7.58% year to date share price return at a last close of $30.24 and a very large 1 year total shareholder return of 265.66%. This has come...

Range Resources Corporation recently reported past fourth-quarter and full-year 2025 results showing higher revenue and net income year-on-year, alongside increased production volumes across natural gas, NGLs and oil, and the Board approved an 11% increase in the quarterly cash dividend to US$0.10 per share, payable on March 27, 2026. The company’s 2026 production guidance of approximately 2.35–2.40 Bcfe per day, with liquids above 30% of output, highlights a growing liquids mix that could...

In recent days, First Interstate BancSystem has come under pressure as analysts turned bearish following a 2.5% annual revenue decline over the last two years and expectations for a 5.2 percentage point deterioration in its efficiency ratio over the next year. This shift in sentiment highlights growing concern that weaker productivity and stalled capital generation could weigh on the bank’s near-term operating profile and flexibility. We’ll now examine how the expected deterioration in First...

Tyra Biosciences (TYRA) is back in focus after reporting fourth quarter and full year 2025 results, with a wider net loss that puts its clinical spending and cash burn firmly on investors’ radar. See our latest analysis for Tyra Biosciences. Despite the wider loss, Tyra Biosciences’ 1-day share price return of 1.45% and 7-day share price return of 7.75% suggest investors are still reacting to the earnings update and its implications for clinical progress. The very large 1-year total...

Hess Midstream LP recently authorized a share repurchase plan, entering into an agreement with JPMorgan Chase Bank to buy back up to US$42,000,000 of Class A shares, initially receiving 744,492 shares, funded through its existing revolving credit facility, with all repurchased shares to be cancelled and final settlement expected in March 2026. These buybacks, alongside the earlier US$18,000,000 Class B unit repurchase from a Chevron affiliate, mark a coordinated effort to reduce outstanding...

In recent days, Southwest Airlines has faced criticism for enforcing a strict no–seat-change policy even on sparsely filled flights, setting it apart from many peers that allow more flexibility. At the same time, the airline is contending with higher oil prices tied to Middle East tensions, intensifying pressure on jet-fuel costs, one of its largest expenses. We’ll now examine how surging fuel-cost pressures interact with Southwest’s evolving service model to reshape the company’s broader...

In February 2026, Weis Markets, Inc. disclosed that it would be unable to file its next Form 10-K with the SEC by the required deadline, signaling a delay in its annual report. This filing delay is material because it can prompt closer scrutiny of the company’s financial reporting processes and internal controls by investors and regulators alike. We’ll now examine how this unexpected 10-K filing delay may influence Weis Markets’ investment narrative and perceptions of its reporting...

DENTSPLY SIRONA (XRAY) shares have been in focus after quarterly results that combined higher fourth quarter sales and a smaller net loss with an earnings miss, a cautious 2026 outlook, and sizeable impairment charges tied to softer U.S. demand. See our latest analysis for DENTSPLY SIRONA. The earnings miss, sizeable impairments and cautious 2026 sales guidance have fed into recent volatility, with a 1-day share price return of 4.43% decline and a 7-day share price return of 10.97% decline,...

Recently, Blue Bird moved to acquire Girardin’s 50% stake in the Micro Bird joint venture, aiming for full control of operations and an expanded range of Buy America–compliant school buses, while its Chief Operating Officer Jeffrey Scott Sanfrey sold 5,192 company shares. This combination of consolidating a key JV and refining leadership share exposure highlights Blue Bird’s continued efforts to align its product mix and governance with evolving policy and manufacturing priorities. We’ll now...

Market reaction to Brown & Brown’s latest quarter Brown & Brown (BRO) recently reported quarterly results that fell short of revenue and organic growth expectations, even though it posted the fastest revenue growth among its insurance brokerage peers. The disappointment around those revenue figures appears to have weighed on sentiment, with the stock down 3.8% since the release. This has put extra attention on how the business is positioned within a still supportive insurance brokerage...

Why Sphere Entertainment Has Caught Investor Attention Sphere Entertainment (SPHR) has been drawing more interest lately, with the stock showing a mix of short term pullbacks and stronger returns over the past month and over the past three months. See our latest analysis for Sphere Entertainment. At a share price of $112.82, Sphere Entertainment has seen short term share price softness, with a 1 day return of a 0.85% decline and a 7 day return of a 1.38% decline, set against a 30 day share...

Intuit (NasdaqGS:INTU) announced a new partnership with Anthropic to integrate the Claude Agent SDK into the Intuit platform. The collaboration is designed to let mid market businesses deploy custom AI agents that reflect their own workflows and financial processes. Intuit also plans to embed its financial intelligence into Anthropic's ecosystem as part of the agreement. For you as an investor, this sits at the intersection of AI tools and core financial software. Intuit already focuses on...

Alignment Healthcare (ALHC) is back in focus after an existing stockholder sold about 13.2 million shares in a secondary offering, increasing public float and liquidity without adding new capital to the company. See our latest analysis for Alignment Healthcare. The secondary sale and recent shelf registration have come alongside mixed price action, with the 1 month share price return of 15.22% and year to date share price return of 8.8% contrasting with a 1 year total shareholder return of...

In February 2026, Acadia Healthcare Company reported fourth-quarter 2025 revenue of US$821.46 million but recorded a net loss of US$1.18 billion, largely driven by a US$996.20 million non-cash goodwill impairment, even as full-year 2025 sales reached US$3.31 billion. Despite the large impairment-driven loss, management issued 2026 revenue guidance of US$3.37 billion to US$3.45 billion and flagged a modest 0%–1% same-facility volume range, highlighting how policy changes in New York Medicaid...

Amazon Web Services data centers in the UAE and Bahrain were struck by drones during ongoing regional conflicts. The attacks caused outages and structural damage to key cloud facilities that support customers across the Middle East. The incident highlights physical security risks for cloud infrastructure and raises concerns about service continuity in conflict zones. For Amazon.com (NasdaqGS:AMZN), this comes at a time when the stock is trading at $213.21, with a 9.6% return over the past...

In early March 2026, Micron Technology began shipping customer samples of its 256GB SOCAMM2 LPDDR5X-based module, the industry’s highest-capacity low-power DRAM for AI data centers, while also ramping its new Sanand, India assembly and test facility for global DRAM and NAND products. These moves underline Micron’s push to pair advanced low-power data-center memory with a broader, more diversified manufacturing footprint that can support AI-driven demand worldwide. We’ll now examine how...

Why the new Voya distribution deal matters for F&G Annuities & Life (FG) F&G Annuities & Life (FG) has agreed to make its annuity products available through Voya Financial's Wealth Management platform, giving Voya advisors another set of retirement and income options for their clients. For you as an investor, this new distribution channel raises practical questions about how wider access to F&G products could influence the company’s reach in the retirement market and how you might view FG...

Alphabet (NasdaqGS:GOOGL) is facing a wrongful death lawsuit alleging its Gemini AI chatbot contributed to a user's death by failing to trigger safety interventions. The claim centers on accusations that Gemini reinforced harmful narratives and did not provide adequate safeguards to prevent real world harm. This is described as the first reported wrongful death case tied directly to Google's AI services, placing fresh legal and ethical focus on AI safety systems. Alphabet sits at the center...

What J.B. Hunt’s dual Nasdaq Texas listing means for shareholders J.B. Hunt Transport Services (JBHT) is set to begin trading its common stock on the newly established Nasdaq Texas exchange, a dual listing aimed at broadening investor access and improving trading flexibility. Because this new listing does not replace the existing Nasdaq Global Select Market listing, it effectively adds another venue where the same shares can trade. For you as an investor, the key questions are how this might...

AAON (AAON) is back in focus after reporting record quarterly revenue, strong backlog growth in its BASX data center segment, and issuing fresh 2026 guidance that points to continued double digit top line expansion. See our latest analysis for AAON. Despite the record revenue update and new product progress, AAON’s recent 7 day share price return of 15.66% and 1 day move of a 4.40% decline suggest momentum has cooled, even as the 1 year total shareholder return of 11.21% and 3 year total...

In recent days, Deutsche Bank upgraded Dauch Corporation to Buy and Jefferies initiated coverage with a Buy rating, adding to an increasingly positive analyst consensus on the company. This shift signals that a growing group of research houses is reassessing Dauch’s prospects more favorably, potentially broadening institutional attention and liquidity. We’ll now examine how this wave of Buy ratings and stronger analyst consensus could influence Dauch’s existing investment narrative and...

Recent partnerships around Arm based CPUs for distributed AI infrastructure and autonomous vehicles put Arm Holdings (ARM) in focus for investors watching how AI workloads spread across edge, cloud, and automotive applications. See our latest analysis for Arm Holdings. Despite a string of AI focused partnerships and conference appearances, Arm Holdings’ recent share price performance has cooled. The 30 day share price return is 7.53% and the 90 day share price return is 19.41%, while the 1...

In early March 2026, Kontoor Brands reported past fourth-quarter and full-year 2025 results showing higher sales and earnings per share, alongside new 2026 guidance and completion of a share repurchase program totaling US$110.02 million for 1,583,143 shares. A key highlight was the contribution from newly acquired Helly Hansen, which significantly lifted quarterly revenue and underpinned management’s confidence in a stronger earnings profile for 2026. With this backdrop, we’ll now assess how...

In February 2026, Aurinia Pharmaceuticals reported fourth-quarter 2025 revenue of US$77.11 million and full-year revenue of US$283.06 million, alongside a very large increase in net income and earnings per share versus 2024. On the same day, the company issued 2026 guidance calling for total revenue of US$315 million to US$325 million and net product sales of US$305 million to US$315 million, signaling management’s confidence in its operating momentum and product demand. We’ll now examine...